Medesis Pharma SA (ALMDP) — Working Capital to Net Assets Ratio
Medesis Pharma SA (ALMDP) has a Working Capital to Net Assets ratio of 40.6% as of June 2024. Working capital of €-2.07 Million (current assets of €1.74 Million minus current liabilities of €3.81 Million) is measured against net assets of €-5.10 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Medesis Pharma SA to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Medesis Pharma SA Working Capital to Net Assets (2018–2023)
This chart shows how Medesis Pharma SA's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2018 to 2023. As of June 2024, the ratio stands at 40.6%, reflecting working capital of €-2.07 Million against net assets of €-5.10 Million EUR. Check ALMDP tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Medesis Pharma SA (2018–2023)
The table below presents the year-by-year Working Capital to Net Assets ratio for Medesis Pharma SA from 2018 to 2023, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Medesis Pharma SA market capitalisation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 56.0% | €-2.52 Million | €-4.50 Million | €1.53 Million | €4.05 Million | ▲ +2.8 pp |
| 2022 | 53.2% | €-562.37K | €-1.06 Million | €1.37 Million | €1.93 Million | ▼ -72.7 pp |
| 2021 | 125.9% | €2.07 Million | €1.65 Million | €3.79 Million | €1.72 Million | ▲ +58.9 pp |
| 2020 | 67.0% | €-1.40 Million | €-2.08 Million | €590.59K | €1.99 Million | ▲ +63.3 pp |
| 2019 | 3.7% | €-90.00K | €-2.42 Million | €431.00K | €521.00K | ▼ -10.8 pp |
| 2018 | 14.5% | €-127.00K | €-876.00K | €440.00K | €567.00K | — |